Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Unresectable”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01657591
What this trial is testing

Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Study completedNCT02306850
What this trial is testing

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

Who this might be right for
Unresectable Malignant NeoplasmMelanomaMetastatic Melanoma+2 more
St. Louis University 10
Early research (Phase 1)Ended earlyNCT07076550
What this trial is testing

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Who this might be right for
Melanoma MetastaticUveal Melanoma, MetastaticMucosal Melanoma
Alpha-9 Oncology USA Inc. 5
Large-scale testing (Phase 3)Study completedNCT01515189
What this trial is testing

Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab

Who this might be right for
Melanoma
Bristol-Myers Squibb 831
Early research (Phase 1)Study completedNCT05003622
What this trial is testing

Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors

Who this might be right for
BRAF V600E Unresectable or Metastatic MelanomaBRAF V600E Metastatic NSCLCMelanoma
Pierre Fabre Medicament 3
Early research (Phase 1)WithdrawnNCT05653661
What this trial is testing

Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Melanoma
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT01247623
What this trial is testing

Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Oslo University Hospital
Early research (Phase 1)Study completedNCT01271803
What this trial is testing

Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 131
Early research (Phase 1)Active Not RecruitingNCT05907304
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 86
Testing effectiveness (Phase 2)Ended earlyNCT01754376
What this trial is testing

Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma

Who this might be right for
Melanoma
Massachusetts General Hospital 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00602576
What this trial is testing

Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Melanoma (Skin)
Abramson Cancer Center at Penn Medicine 169
Early research (Phase 1)Ended earlyNCT04967196
What this trial is testing

Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+1 more
Mayo Clinic 6
Very early researchNot Yet RecruitingNCT07700121
What this trial is testing

PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Ended earlyNCT00082875
What this trial is testing

Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Stage III MelanomaStage IV Melanoma
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT01927419
What this trial is testing

Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma

Who this might be right for
Unresectable MelanomaMetastatic Melanoma
Bristol-Myers Squibb 142
Early research (Phase 1)Study completedNCT05303493
What this trial is testing

Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma

Who this might be right for
NSCLC Stage IVMelanoma Stage IVUnresectable Melanoma+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 45
Testing effectiveness (Phase 2)Ended earlyNCT01551693
What this trial is testing

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT01990859
What this trial is testing

Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients

Who this might be right for
Melanoma
Bristol-Myers Squibb 20
Early research (Phase 1)WithdrawnNCT04759846
What this trial is testing

Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma

Who this might be right for
BRAF V600 MutationUnresectable MelanomaMetastatic Melanoma+1 more
Pierre Fabre Medicament
Next Page